News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Dendrite International, Inc. Provides Outlook For Fourth Quarter 2006 & Full Year 2007
December 15, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BEDMINSTER, N.J.--(BUSINESS WIRE)--Dendrite International, Inc. (NASDAQ: DRTE) today provided its revenue and earnings per share outlook for the fourth quarter 2006 and its preliminary outlook for the full year 2007.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
FDA
UPDATE: FDA disputes Capricor’s claims of Phase 3 success for DMD cell therapy
July 27, 2026
·
3 min read
·
Heather McKenzie
Business
Gossamer regains rights to lung disease asset from Chiesi after Phase 3 fail
July 27, 2026
·
3 min read
·
Gabrielle Masson
C-suite
Sarepta names former AbbVie R&D exec Michael Severino as next CEO
July 27, 2026
·
3 min read
·
Annalee Armstrong
Earnings
AstraZeneca has no plans to ramp up dealmaking in wake of Wainua failure
July 27, 2026
·
3 min read
·
Tristan Manalac